Zebrafish Screening Identifies Erlotinib as a Wnt/β-Catenin Inhibitor in T-ALL, Biomedicine and Pharmacotherapy (2024)
The Wnt/β-catenin pathway is important in cancer and stem cell biology, making it a potential target for therapy. However, using Wnt inhibitors in the clinic is difficult due to off-target effects and interactions with other pathways. In this study, we…